Laboratorios Farmaceuticos ROVI SA
Zehra Kahveci, PhD, has a strong background in both pharmaceutical marketing and research, having held positions such as Jefe de Producto and Jefe de Producto Junior at ROVI Pharmaceutical Company, and began a career as a Marketing Intern. In the research sector, Zehra has served as a Postdoctoral Research Associate at both the Consejo Superior de Investigaciones Científicas and the University of Exeter. Currently pursuing a PhD in Cellular and Molecular Biology at Universidad Miguel Hernández de Elche, Zehra also has specialized training in Molecular and Cellular Biology techniques from the same institution.
This person is not in the org chart
This person is not in any teams
Laboratorios Farmaceuticos ROVI SA
Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company's main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.